Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://myaxkix386687.fitnell.com/79814163/retaglutide-a-promising-glp-1-receptor-agonist